09.02.2014 Views

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Mendel rats, respectively), and subcutaneous leiomyosarcoma (7% in Japanese rats). Cirrhosis was<br />

reported in all animals. Due to the small group size, poor survival of several strains and the incomplete<br />

reporting of the total dosage, and most importantly, the inappropriate route of exposure (subcutaneous<br />

injections), this study was not used in a quantitative risk assessment. As in the mouse studies, NCI used<br />

carbon tetrachloride as a positive control in rat bioassays for chloroform, 1,1,1-trichloroethane and<br />

trichloroethylene (NCI, 1976a,b; 1977; Weisburger, 1977). The Osborne-Mendel rats were<br />

administered a time-weighted average dose of carbon tetrachloride by gavage for 78 weeks (47, 97<br />

and 80, 159 mg/kg body weight, respectively for males and females). Hepatic carcinomas were found<br />

at both doses in both sexes (4%, 4% and 8%, 2% in low and high dosage, males and females,<br />

respectively). A lower incidence was reported in the high-dose females, but this may have been a result<br />

of that dose group’s high mortality rate prior to tumor expression. Tumors in other tissues were not<br />

discussed.<br />

Male and female Syrian golden hamsters were administered carbon tetrachloride in corn oil weekly by<br />

gavage (190 and 380 mg/kg of body weight, respectively) for a total of 30 weeks (Della Porta et al.,<br />

1961). Following treatment, the animals were kept 25 weeks, sacrificed and examined. Only eight of<br />

the original 20 animals survived the full 55 weeks. Carcinomas were not observed in the animals that<br />

died prior to the 43 rd week, but one or more liver-cell carcinomas were reported in all the surviving<br />

animals, indicating that tumors may be produced at lower levels in this species. Liver tumor incidence in<br />

carbon tetrachloride-treated animals (males and females combined) was 10/19 (53%) compared to<br />

0/80 (0%) for controls.<br />

In summary, carbon tetrachloride has been shown to produce liver tumors in mice, rats and hamsters by<br />

the oral and subcutaneous routes. No inhalation cancer bioassays have been conducted.<br />

IV.<br />

DERIVATION OF CANCER POTENCY<br />

Basis for Cancer Potency<br />

Carbon tetrachloride has been observed to induce liver tumors in male and female hamsters, mice and<br />

rats, as described above. CDHS (1987) decided that the tumor incidence data from studies by Della<br />

Porta et al. (1961) (hamster), Edwards et al. (1942) (mouse) and NCI (1977a, b) (mouse) were<br />

suitable for use in developing a quantitative risk assessment.<br />

Methodology<br />

A health assessment document for carbon tetrachloride was prepared by US EPA (1984). This<br />

document contained a quantitative cancer risk assessment for carbon tetrachloride. A linearized<br />

multistage procedure was applied to liver tumor incidence data (Della Porta et al., 1961; Edwards et<br />

al., 1942; NCI 1976a, b; 1977 [rat, mouse]) to estimate a cancer unit risk.<br />

The quantitative risk assessment of carbon tetrachloride conducted by US EPA (1984) using the<br />

linearized multistage procedure was modified by DHS (1987) by: 1) applying an absorption fraction of<br />

164

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!